Skip to main content

Main menu

  • Home
  • About
    • JALM
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
    • Special Issues & Collections
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Abstracts
  • JALM Talk
  • Submit
  • Feedback
  • Other Publications
    • Clinical Chemistry

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
The Journal of Applied Laboratory Medicine
  • Other Publications
    • Clinical Chemistry
  • Subscribe
  • My alerts
  • Log in
The Journal of Applied Laboratory Medicine

Advanced Search

  • Home
  • About
    • JALM
    • Editorial Board
    • Most Read
    • Most Cited
    • Alerts
  • Articles
    • Current Issue
    • Early Release
    • Future Table of Contents
    • Archive
    • Browse by Subject
    • Special Issues & Collections
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Advertisers
    • Permissions & Reprints
  • Abstracts
  • JALM Talk
  • Submit
  • Feedback
Research ArticleFocused Reports

Assay Integrity of a PCR Influenza Point-of-Care Test Remains Following Artificial System Contamination

Jamie E. Phillips, Stephen McCune, Corinne R. Fantz, Julia Engstrom-Melnyk, John C. Osiecki
DOI: 10.1373/jalm.2018.028639 Published October 2019
Jamie E. Phillips
Roche Diagnostics Corporation, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen McCune
Roche Diagnostics Corporation, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Corinne R. Fantz
Roche Diagnostics Corporation, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Engstrom-Melnyk
Roche Diagnostics Corporation, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John C. Osiecki
Roche Diagnostics Corporation, Indianapolis, IN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: john.osiecki@roche.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Healthcare providers who have access to tests at the point of care (POC) are increasingly requesting the same performance from the POC test as they expect from the laboratory. With the introduction of the cobas® Liat instrument, highly sensitive molecular diagnostic testing can be performed closer to the patient in CLIA-waived, POC settings. As more sensitive tests become available, there is concern regarding contamination of instrumentation owing to improper handling, mistakes made when processing, or environmental contamination. Recent concerns were raised when a nurse performed environmental surveillance for flu A/B by inserting a dry swab into the cobas Liat instrument and then ran it as a sample on the instrument, generating a positive result. This finding stimulated questions about the possibility of system contamination contributing to false-positive results, ultimately leading to the possibility of providing incorrect treatment to patients.

Methods: To assess the likelihood of system contamination contributing to the generation of false-positive results, in this study we contaminated a cobas Liat System with flu A/B-positive control material. The system contamination was then assessed by swabbing exposed surfaces. Following confirmed system contamination, negative control samples were processed to determine whether system contamination had an impact on the expected negative results.

Results: Instrument contamination was confirmed, and no detectable flu A/B signal was observed for any of the negative control tubes run immediately following confirmation of system contamination.

Conclusion: Environmental contamination of the Liat instrument does not have an impact on the integrity of the result.

Footnotes

  • Authors' Disclosures or Potential Conflicts of Interest: Upon manuscript submission, all authors completed the author disclosure form.

  • Employment or Leadership: J.E. Phillips, Roche Diagnostics; S. McCune, Roche Diagnostics; C.R. Fantz, AACC Board of Directors; J. Engstrom-Melnyk, Roche Diagnostics Corporation; J.C. Osiecki, Roche Diagnostics Corporation.

  • Consultant or Advisory Role: S. McCune, Roche Diagnostics.

  • Stock Ownership: S. McCune, Roche Diagnostics; C.R. Fantz, Roche Diagnostics; J. Engstrom-Melnyk, Roche Diagnostics Corporation; J.C. Osiecki, Roche Holding AG.

  • Honoraria: S. McCune, Roche Diagnostics.

  • Research Funding: Roche Diagnostics.

  • Expert Testimony: None declared.

  • Role of Sponsor: The funding organizations played no role in the design of study, choice of enrolled patients, review and interpretation of data, preparation of manuscript, or final approval of manuscript.

  • Previous presentation of this work: Abstract/Poster submitted to the Clinical Virology Symposium, 2018, West Palm Beach, FL; Abstract/Poster submitted to American Association for Clinical Chemistry, CPOCT, 2018, Washington, DC.

  • Received December 10, 2018.
  • Accepted April 8, 2019.
  • © 2019 American Association for Clinical Chemistry
View Full Text

Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$15.00

Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

Log in using your username and password

Forgot your user name or password?
Forgot your username or password?

Log in through your institution

If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
PreviousNext
Back to top

In this issue

The Journal of Applied Laboratory Medicine: 4 (3)
Vol. 4, Issue 3
November 2019
  • Table of Contents
  • About the Cover
  • Index by author
  • Table of Contents (PDF)
  • Cover (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Share
Assay Integrity of a PCR Influenza Point-of-Care Test Remains Following Artificial System Contamination
Jamie E. Phillips, Stephen McCune, Corinne R. Fantz, Julia Engstrom-Melnyk, John C. Osiecki
The Journal of Applied Laboratory Medicine Nov 2019, 4 (3) 422-426; DOI: 10.1373/jalm.2018.028639
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Assay Integrity of a PCR Influenza Point-of-Care Test Remains Following Artificial System Contamination
Jamie E. Phillips, Stephen McCune, Corinne R. Fantz, Julia Engstrom-Melnyk, John C. Osiecki
The Journal of Applied Laboratory Medicine Nov 2019, 4 (3) 422-426; DOI: 10.1373/jalm.2018.028639

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Dilution Method to Mitigate Biotin Interference in Cardiac Troponin T Testing
  • Prevalence of Clinically Significant Differences in Sodium Measurements Due to Abnormal Protein Concentrations Using an Indirect Ion-Selective Electrode Method
Show more Focused Reports

Similar Articles

Subjects

  • Point-of-Care Testing

Navigate

  • Home
  • About
  • Articles
  • Information for Authors
  • Submit

Other Publications

  • Clinical Chemistry
Footer logo

© 2019 American Association for Clinical Chemistry

Powered by HighWire